Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
Clinical trial NCT06370000 · RECRUITING
Trial details
- NCT number
- NCT06370000
- Sponsor
- Virginia Commonwealth University
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-07
- Primary completion
- 2027-01-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.